期刊文献+

武汉市青光眼患者局部药物治疗依从性调查 被引量:6

Survey of compliance in patients with topical glaucoma therapy in Wuhan
下载PDF
导出
摘要 目的:调查武汉市青光眼患者局部使用降眼压药物的依从性及影响因素。方法:一对一应用调查表对2014-07/2015-06在我院已确诊并接受局部青光眼药物治疗6mo以上的武汉市区及周边城区的366例青光眼患者,进行用药依从性调查,并对影响因素进行分析。结果:青光眼患者局部用药依从性为44.3%(162/366)。患者较好眼的病情程度、发病时症状轻重、持续用药时间及是否每天固定时间用药与用药依从性相关(OR=5.700,0.554,0.336,0.558,P<0.05),患者年龄、性别、婚姻状态、文化程度、经济状况、居住地、青光眼知识的了解程度、需要治疗的全身疾病情况、青光眼类型、用药种类、用药次数等因素与局部用药依从性无相关。结论:武汉市青光眼患者局部用药治疗依从性较差,定期进行相关健康教育和干预措施尤为重要。 AIM : To investigate the compliance in patients with topical glaucom a therapy,and identify the most frequent barriers to adherence.METHODS: One-on-one interviewand questionnaire were taken to investigate the com pliance with hypotensive eye drops in 366 patients who had been diagnosed as glaucom a and received the therapy for at least 6mo in Wuhan and suburban district from July 2014 to June 2015 in Wuhan Aier Eye Hospital. RESULTS: The proportion of compliance was 44. 3%( 162/366). Factors significantly influencing compliance included severity of the better eye, the severity of sym ptom when attacked, duration of medication and whether to adm inistrate on the sam e time daily( OR =5. 700,0. 554,0. 336,0. 558,P 0. 05). Age,gender,m arital status, education level, economic status, dom icile,knowledge of the disease,suffering from other diseases with m edication,type of glaucom a,type of eye drop,frequency were not associated with a higher rate of non-com pliance. CONCLUSION: Compliance in patients with topical glaucom a therapy in Wuhan is poor. Regularly carrying out relevant health education and interventions is very im portant.
作者 孙重 赵敏
出处 《国际眼科杂志》 CAS 2016年第6期1144-1146,共3页 International Eye Science
关键词 青光眼 依从性 影响因素 glaucoma compliance influence factor
  • 相关文献

参考文献11

  • 1Olthoff CM, Schouten JS, Borne BW, et al. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology 2005; 112(3): 953-961.
  • 2Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010and 2020.Br J Ophthalmol 2006; 90(3):262-267.
  • 3Konstas AG, Maskaleris G, Gratsonidis S,et al.Compliance and viewpoint of glaucoma patients in Greece. Eye 2000; 14(5):752-756.
  • 4Zolnierek K, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Medical Care 2009; 47(4): 826-834.
  • 5Kholdebarin R, Campbell RJ, Jin YP,et al.Multicenter study of compliance and drop administration in glaucoma. Can J Opbthalmol 2008; 43(4):454-461.
  • 6Kowal M, Choragiewicz T, Mietlicka K,et al.Obstacles to medication compliance for patients with glaucoma.Klin Oczna 2008; 110(10-12):347-351.
  • 7Waterman H, Evans JR, Gray TA, et al. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev 2013; 4:CD006132.
  • 8Leske MC, Heijl A, Hussein M,et al.Factors for glaucoma progression and the effect of treatment:the early manifest glaucoma trial. Arch Ophthalmol 2003; 121(1):48-56.
  • 9Sleath B, Blalock S, Covert D,et al.The relationship between glaucoma medication adherence, eye drop technique and visual field defect severity. Ophthalmology 2011; 118(10): 2398-2402.
  • 10Bron A, Baudouin C, Denis P,et al.Satisfaction and compliance of ocular hypertensive and glaucoma patients topically treated with a combination therapy. J Fr Ophtalmol 2008; 31(7):659-665.

同被引文献39

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部